Company ProfilePremium

Amal Ltd

Company Profile Analysis

Ticker: 506597.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Amal Ltd - Company showcase

Year Founded & Workforce

1974

81 Employees

Amal Ltd logo

Amal Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Amal Ltd Overview

Amal Ltd is a small, debt-free maker of sulphur-based bulk chemicals controlled by Atul Ltd, one of India's largest integrated chemical companies. Its main job is backward integration for Atul. Its plants at Ankleshwar, Gujarat sit next to Atul's aromatics complex and have a combined 440 tonnes per day (TPD) of sulphuric-acid-equivalent capacity: 140 TPD in Amal itself and 300 TPD in its wholly owned subsidiary ASCL. They produce sulphuric acid, oleum, sulphur dioxide and sulphur trioxide, and sell by-product steam. About 38% of consolidated revenue comes from Atul. The rest goes to merchant customers in dyestuffs, pharmaceuticals, petrochemicals, textiles and personal care. Economics are driven almost entirely by the spread between product prices and the cost of sulphur, which is about 85% of costs. As a result, revenue swings with sulphur prices more than with volumes. Parent support, full capacity utilisation and a net-cash balance sheet make Amal a high-quality but structurally small, single-product, captive-anchored business.


What the company does. Amal makes bulk chemicals by burning sulphur. Elemental sulphur is burned to make sulphur dioxide (SO2), which is converted catalytically to sulphur trioxide (SO3) and absorbed to give sulphuric acid (H2SO4, mainly 98%) and oleum (fuming sulphuric acid). Liquid SO2 and SO3 are also sold as downstream products in their own right. The process is strongly exothermic, so the plants recover heat as steam. Since June 2023 steam has been sold to Atul and is now a meaningful revenue line, at about 16% of FY2026 revenue according to CARE, which puts sulphur-based products at about 84%.

Company's own description. Amal's annual reports (FY2015-16 through FY2025-26) describe the company as engaged in manufacturing and marketing bulk chemicals such as sulphuric acid and oleum and their downstream products such as sulphur dioxide and sulphur trioxide, with its plant at Ankleshwar, Gujarat. IIFL's summary of company disclosures adds that these chemicals are used in dyestuff, fertiliser, personal care, petrochemical, pharmaceutical and textile industries.

Business model and revenue model.

Independent characterisation. Amal is best understood as a captive utility for Atul that also sells into the merchant market. Atul built the ASCL facility to secure consistent, quality sulphuric acid supply, protect itself against volatile market prices and save freight (CARE). The arrangement gives Amal low sales risk and full utilisation, as CARE says it ran at full capacity in FY2025-FY2026. The trade-off is limited pricing power and exposure to sulphur price spikes that cannot be fully passed through. The steam business is a structural positive: it turns waste heat into revenue with almost no extra cost and ties Amal more closely into Atul's energy system. It also has no direct exposure to commodity-acid price cycles.

Strategy

Stated strategic themes (from annual reports, CARE and board disclosures).

  1. Backward integration for Atul. Amal's operations serve as backward integration for Atul. Plants located near Atul's aromatics division supply sulphuric acid and derivatives at low freight cost (CARE). Atul set up the ASCL facility to secure consistent quality supply, protect against acid-price volatility and save freight.

  2. Full use of the asset base and by-products. The company ran at full utilisation in FY2025–FY2026 and is monetising steam.

  3. Debottlenecking downstream products. The SO2 capacity increase is described by the company as part of its strategic growth plan.

  4. Balance-sheet conservatism. It is debt-free, with internal funding of capex (CARE).

  5. Team values. Annual reports refer to "five everlasting mandates" of team Amal (AR FY2020-21). The diya logo stands for ethics, hard work and purpose (AR FY2018-19).

Initiatives announced in the last 24 months.

Medium-term financial targets / guidance: not publicly disclosed. Amal holds no earnings calls or investor days.

ESG commitments: Amal has made no specific emissions targets public. It sits within the Atul group's CSR programme through Atul Foundation.

Products & Services

All products fall within the single "bulk chemicals" segment and are made at Ankleshwar, Gujarat. Amal does not market products under consumer brands, and price lists are not disclosed.

Historical products (discontinued). Pigments (1,200 tpa), H-Acid and other dye intermediates, and a bulk-drug project were part of the pre-BIFR portfolio (IIFL). None appear in current disclosures.

Flagship offering. The ASCL 300 TPD sulphuric acid plant and its steam stream are the group's flagship asset.

Product Portfolio

ProductDescription and specificationMain applications and target customersProducing entity and capacityLaunch / latest expansionPricing model

Sulphuric acid (H2SO4), mainly 98%

Commodity mineral acid made by the contact process from burnt sulphur

Atul's aromatics and intermediates plants; dyestuffs, pharma, textiles, petrochemicals, fertilisers

Amal 140 TPD + ASCL 300 TPD = 440 TPD (sulphuric acid equivalent)

Amal plant operational FY2008-09 and expanded FY2011-12; ASCL commissioned FY2023

Merchant/contract pricing linked to sulphur costs. Supply to Atul is arm's-length related-party sales; contract terms not disclosed.

Oleum (fuming sulphuric acid; grades not disclosed)

H2SO4 with dissolved SO3; a strong sulphonating agent

Dye intermediates, sulphonation chemistry, explosives and pharma intermediates

Shared capacity within the 440 TPD

Oleum project implemented historically (undated)

—

Sulphur dioxide (SO2), liquid

Liquefied SO2 drawn from the burner stage

Bleaching, food and pharma processing, sulphite chemistry, water treatment, chemical synthesis

Amal: 45 TPD, being raised to 105 TPD (₹12 cr capex approved 17 Jul 2026; about two years to complete)

Plant set up FY2011-12

—

Sulphur trioxide (SO3), liquid

Stabilised liquid SO3

Sulphonation for detergents (LABSA) and personal care surfactants, dyes

Capacity not separately disclosed

Plant set up FY2011-12

—

Steam (utility)

By-product steam from exothermic sulphur combustion, recovered through waste-heat boilers

Atul's Ankleshwar complex

Volume not disclosed. A steam pipeline is in the ~₹25 cr capex programme to improve steam utilisation (CARE).

Steam sales to Atul began June 2023

Not disclosed; about 16% of FY2026 revenue

“—” = not publicly disclosed.

Financial Narrative

All figures are consolidated, ₹ crore, fiscal years ending 31 March. FY2022–FY2024 are from Screener (rounded). FY2025–FY2026 are from the Directors' Report FY2025-26 and CARE Oct 2026, supplemented by quarterly sums from Screener.

Income statement

Notes. Gross profit is not reported, because Indian Ind AS statements are presented by nature of expense. Simply Wall St's trailing-twelve-month (TTM) data imply gross profit of about ₹58 cr on ₹290 cr revenue. Diluted EPS equals basic because there are no dilutive instruments. FY2025 other income, depreciation and interest are sums of Screener quarterly data. FY2026 depreciation (₹9.31 cr) and finance cost (₹0.65 cr) are from Fyers' summary of FY2026 accounts.

Margins and growth

Revenue CAGR: FY2022–FY2026 (4-year) about 53.7% (computed). FY2021–FY2026 (5-year) about 51.6%, against Screener's 51%. Profit CAGR over 5 years is about 21% (Screener).

Quarterly trajectory (last six quarters)

Source: Screener consolidated quarterly table. Q1 FY2027 other income includes a one-time recognition of ₹5.61 cr of government incentives for ASCL (FilingReader summary of the 17 Jul 2026 filing). Q2 FY2027 standalone profit was ₹4.01 cr (BSE outcome, 16 Oct 2026).

H1 FY2027 compared with H1 FY2026: revenue ₹227.8 cr vs ₹101.3 cr (+125%); net profit ₹22.9 cr vs ₹15.5 cr (+48%). TTM to Sep 2026: revenue ₹366 cr, net profit about ₹30 cr, EPS ₹24.11 (Screener).

Balance sheet

Notes:

  • Equity per CARE is ₹99.0 cr for FY2025 and ₹120.4 cr for FY2026.

  • The short-term versus long-term debt split is not disclosed in the sources reviewed. CARE confirms nil fund-based borrowings at 31 Mar 2026 and no scheduled debt obligations in FY2027.

  • Goodwill and intangibles: none disclosed; no acquisitions have been made.

  • Cash and equivalents are not separately reported in the Screener summary. CARE reports ₹30.7 cr at 30 Jun 2026.

  • Equity at 30 Sep 2026 was about ₹141 cr, total assets about ₹195 cr, and borrowings nil (Screener half-year balance sheet).

  • Book value per share was ₹114 in Sep 2026.

Net debt:

  • FY2022–FY2024: positive. Gross debt was ₹51 cr, ₹35 cr and ₹24 cr, against cash that is not separately disclosed.

  • FY2025–FY2026: net cash. Debt is nil, with ₹20 cr and ₹37 cr of investments.

Working capital: CARE reports a current ratio of 1.89x at 31 Mar 2025 and 2.48x at 31 Mar 2026. Screener working-capital days moved from -11 in FY2025 to +7 in FY2026.

Cash flow

Source: Screener. Capex is derived as CFO minus FCF. Dividend paid in FY2026 is derived from the ₹1 per share FY2025 dividend on 12.36 million shares. The FY2023 financing inflow includes the ₹49.94 cr rights issue, net of ₹36 cr debt repayment. CARE reports gross cash accruals of ₹35.0 cr in FY2026.

Ratios

Notes:

  • FY2025 and FY2026 interest coverage are CARE figures (21.53x, 54.57x). Earlier years are computed from rounded Screener data.

  • ROIC is not separately computed; ROCE is shown as the proxy.

  • Net debt/EBITDA is not meaningful. In FY2025–FY2026 the company had net cash. In FY2022 gross debt/EBITDA was about 12.8x. In FY2023 EBITDA was negative. In FY2024 gross debt/EBITDA was about 1.6x.

  • ROE and ROA use average balances. The FY2021 opening values are equity ₹34 cr and assets ₹48 cr.

Commentary on trends, inflections and drivers

FY2022–FY2023: the investment trough. ASCL's construction pushed capex to about ₹63 cr in FY2022, with ₹66 cr in CWIP at year-end, funded mainly by borrowings that reached ₹51 cr and a debt/equity of 1.46x. In FY2023 the new plant was commissioned but could not run fully (AR FY2022-23). Depreciation rose to about ₹7 cr and interest to about ₹4 cr, producing a ₹16 cr net loss. The ₹49.94 cr rights issue in March 2023 repaired the balance sheet and cut debt by ₹36 cr.

FY2024: stabilisation. Capacity utilisation improved after ASCL stabilised (CARE Oct 2024). Steam sales to Atul from June 2023 added a high-margin stream. EBITDA margin recovered to about 17%. Profit stayed thin at about ₹2 cr because depreciation and interest absorbed most of the EBITDA.

FY2025: the peak-margin year. Revenue grew 57% to ₹135 cr and EBITDA margin reached 32.3%. Volume, steam and a still-moderate average sulphur cost all contributed; CARE puts sulphur at US$157/MT on average in FY2025 against US$107/MT in FY2024. Net profit of ₹29.3 cr was a record, consistent with Atul's statement that Amal and ASCL recorded their highest sales and PBT so far. The company became debt-free.

FY2026: revenue up, margins down. Revenue rose 77% to ₹240 cr. Per CARE, average realisation rose about 93% while volumes rose only about 5%, because average sulphur prices nearly tripled to US$418/MT. Pass-through was incomplete, so EBITDA fell to ₹35.7 cr and margin to 14.9%. Q4 FY2026 was the low point, with a 9.7% margin and a 66% tax rate that cut PAT to ₹1.9 cr.

FY2027 so far: volatility. In Q1, inventory-led gains (CARE) and a ₹5.61 cr one-off incentive lifted PBT to ₹20.9 cr, despite a planned maintenance shutdown that cut volumes by about 15%. In Q2, revenue reached ₹131 cr but margin collapsed to 6.45%, because sulphur rose to about US$1,050/MT on West Asia conflict and supply disruption (CARE Oct 2026). The market reacted with a 20% share-price fall on 16 Oct 2026.

Balance-sheet quality. Despite margin compression, the balance sheet keeps strengthening. Equity grew from ₹99 cr to ₹141 cr between Mar 2025 and Sep 2026, debt is zero and investments are ₹37 cr. Working capital has moved from negative to modestly positive as receivables grow with higher prices.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipActivityCapacity

Amal Ltd (standalone)

Listed parent

Sulphuric acid, oleum, SO2, SO3 at Ankleshwar

140 TPD sulphuric acid; 45 TPD SO2 (expanding to 105 TPD)

Amal Speciality Chemicals Ltd (ASCL)

100% subsidiary; material subsidiary

Sulphuric acid 98% and derivatives; steam to Atul

300 TPD sulphuric acid equivalent

Atul Ltd

Ultimate controlling shareholder (49.86% via Atul Finserv Ltd); Amal is a subsidiary of Atul through control

Largest customer

—

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2024FY2025FY2026

Segment revenue (INR Cr)

86135.3239.6

Segment PBT (INR Cr)

332.628.0

Segment PBT margin (%)

3.524.111.7

YoY revenue growth (%)

415777

Contribution to total revenue (%)

100100100

Revenue by Segment

MetricFY2025FY2026

Consolidated revenue (INR Cr)

135.3239.6

Amal standalone revenue (INR Cr)

48.984.9

Implied ASCL revenue before eliminations (INR Cr)

86.4154.7

Amal standalone PBT (INR Cr)

9.46.3

Implied ASCL PBT (INR Cr)

23.221.6

Amal standalone PAT (INR Cr)

6.94.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (%)

MetricFY2026

Sulphur-based products share of revenue (%)

84

Steam share of revenue (%)

16

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

436186135.3239.6

Total expenses excl. D&A and interest (INR Cr)

40677191.6203.9

EBITDA / PBILDT excl. other income (INR Cr)

4-61543.735.7

Other income (INR Cr)

0100.52.2

Depreciation (INR Cr)

2799.29.3

EBIT incl. other income (INR Cr)

3-12734.628.6

Interest (INR Cr)

1442.00.7

Profit before tax (INR Cr)

2-16332.628.0

Tax (INR Cr)

1013.35.6

Net profit (INR Cr)

1-16229.322.4

EPS basic (INR)

0.90-13.031.3823.6918.10

EPS diluted (INR)

0.90-13.031.3823.6918.10

Dividend per share (INR)

0001.01.5

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

EBITDA margin (%)

9.3-9.817.432.314.9

EBIT margin (%)

7.0-19.78.125.611.9

PBT margin (%)

4.7-26.23.524.111.7

Net margin (%)

2.3-26.22.321.79.3

Revenue growth YoY (%)

4342415777

Effective tax rate (%)

313391020

Income Statement and Margin Analysis (%)

MetricQ1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027Q2FY2027

Revenue (INR Cr)

47.3154.0062.5975.7496.54131.23

Operating profit (INR Cr)

11.638.608.097.3517.098.47

OPM (%)

24.5815.9312.939.7017.706.45

Other income (INR Cr)

0.440.470.590.746.132.15

PBT (INR Cr)

9.596.636.135.6020.878.18

Net profit (INR Cr)

9.406.065.021.9016.736.16

EPS (INR)

7.604.904.061.5413.534.98

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

100118106122154

Net fixed assets (INR Cr)

1490868077

Capital work-in-progress (INR Cr)

661103

Investments (INR Cr)

0012037

Other assets incl. cash, receivables, inventory (INR Cr)

1927192138

Total borrowings (INR Cr)

51352400

Other liabilities (INR Cr)

1415132234

Shareholders' equity (INR Cr)

35687099120

Equity share capital (INR Cr)

9.4312.3612.3612.3612.36

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operations (INR Cr)

-1-10215022

Cash from investing (INR Cr)

-43-16-9-22-22

Cash from financing (INR Cr)

4429-14-25-1

Capex derived (INR Cr)

6316847

Free cash flow (INR Cr)

-64-26134615

Dividends paid derived (INR Cr)

00001.2

Share buybacks (INR Cr)

00000

CFO to EBITDA (%)

-10517214411968

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE computed (%)

2.5-31.12.534.720.4

ROA computed (%)

1.1-14.71.525.716.2

ROCE Screener (%)

4-1273626

Debt to equity (x)

1.460.510.3400

Interest coverage EBITDA to interest (x)

4.0-1.53.821.554.6

Asset turnover computed (x)

0.580.560.771.191.74

Debtor days

1125232730

Inventory days

3426283325

Payable days

4231366838

Cash conversion cycle (days)

42115-917

Revenue by Region and Revenue by Region (%)

MetricFY2025FY2026

Total revenue (INR Cr)

135.3239.6

Revenue from Atul derived (INR Cr)

47.491.0

Revenue from other customers derived (INR Cr)

87.9148.6

Atul share of revenue (%)

3538

Capital Markets

Metric1 year3 years5 years10 years

Stock price return or CAGR (%)

2281528

Share Price History

DatePrice (INR)Market cap (INR Cr)Source

22 Jan 2025

711923

INDmoney

19 Dec 2025

686.90—

ICICIdirect

2 Feb 2026

462.50—

Emkay

21 Apr 2026

653809

Kotak Neo

9 Jun 2026

541.05672

Value Research

17 Jul 2026

752.15 (upper circuit)

—

JM Financial

14 Aug 2026

750—

ICICIdirect

16 Oct 2026

746 (−20% on the day)

923

Screener

Valuation Multiples

MultipleAmalPeer reference

P/E (TTM)

31.0x (Screener)

Peer median 28.68x (Value Research, 9 Jun 2026)

P/B

6.5x (₹746 / BV ₹114)

Peer median 2.90x (Value Research, 9 Jun 2026)

Market cap / Sales (TTM)

About 2.5x (₹923 cr / ₹366 cr)

—

EV / Sales (indicative)

About 2.4x, using ₹37 cr investments as a cash proxy

—

EV / EBITDA (indicative)

About 21.6x on TTM EBITDA of about ₹41 cr. Upstox showed 18.1x in May 2026.

—

Dividend yield

About 0.20%

—

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

0001.01.5

Dividend payout ratio (%)

00048

Analyst Conclusions

Management guidance. No formal guidance. The only forward-looking statements are about capex: the SO2 expansion within about two years, plus the steam pipeline and sulphur storage, about ₹25 cr in total funded internally. CARE's outlook expects strong FY2027 revenue growth from higher realisations and continued healthy utilisation. It expects profitability to stay broadly stable but capped by high sulphur prices and limited pass-through.

Consensus expectations. None (no coverage). Implied run-rate: H1 FY2027 revenue of ₹228 cr points to FY2027 revenue that could exceed ₹400 cr if sulphur-linked prices stay high. This is an analyst extrapolation, not guidance. Profit trajectory is highly uncertain.

Bull case

  1. Spread normalisation. Amal earned a 32% EBITDA margin and ₹29 cr PAT in FY2025 at US$157/MT sulphur. If sulphur retreats from about US$1,050/MT, the much larger revenue base and a debt-free balance sheet could produce record absolute profits.

  2. Self-funded growth with high returns. About ₹25 cr of capex (SO2 +60 TPD, steam pipeline, storage) against a ₹141 cr equity base. Existing SO2 capacity is almost fully used, so incremental returns should be high.

  3. Embedded optionality from Atul. Any further Atul capacity growth (FY2026 revenue +13%) drives captive acid and steam demand. CARE names higher Atul offtake as a positive rating trigger, which hints at further dedicated capacity.

Bear case

  1. Margin trap. Q2 FY2027 OPM of 6.45% on record revenue shows that pass-through fails when sulphur spikes. At about 31x TTM earnings, which include a one-off ₹5.61 cr incentive, the valuation leaves little room if margins stay in single digits.

  2. Captive economics cap upside. About 38% of revenue goes to the controlling shareholder on undisclosed terms. Minority holders depend on the fairness of related-party pricing, and the parent has little incentive to let Amal capture windfall spreads.

  3. Regional supply wave. Large smelter-acid additions in Gujarat (Adani about 1.5 million t/a; GSFC Sikka about 0.6 million t/a) could depress merchant acid prices just as input costs are high.

Key catalysts and things to monitor over the next 12 months

  • International sulphur prices (Middle East FOB and India CFR) and their trajectory from about US$1,050/MT.

  • Q3 FY2027 results (expected Jan 2027): whether OPM recovers from 6.45%.

  • Progress on SO2 expansion, the steam pipeline and the sulphur storage facility.

  • Atul's capacity additions and offtake commitments; related-party transaction disclosures in AR FY2026-27.

  • The rise in working capital (receivables at higher prices) and whether non-fund-based limit usage moves to borrowing.

  • Commissioning and ramp-up of new Gujarat acid supply.

  • Any change in the group structure (consolidation into Atul).

  • Annual planned shutdown timing (typically Q1).

Concluding analyst verdict. Amal Ltd has been rebuilt from a BIFR-era failure into a compact, well-run sulphur-chemicals utility for the Atul group. The rebuild worked: in five years revenue rose from ₹30 cr to ₹240 cr, the balance sheet went from 1.5x debt/equity to net cash, and in FY2025 the company showed that a 440 TPD sulphur-burning complex with steam integration can earn 30%+ EBITDA margins and returns on equity above 30%. The asset base is fully used, parent support is explicit and rated (CARE A+, notched up from Atul's AA+), and management has resumed modest growth capex funded from internal cash.

The investment problem is that Amal's earnings are a function of one variable it does not control: the spread between sulphur and the acid, derivatives and steam it sells. That spread has been squeezed hard. Sulphur moved from about US$157/MT to about US$1,050/MT over roughly eighteen months, and operating margin fell from 32% (FY2025) to 15% (FY2026) and then to 6.5% (Q2 FY2027). Reported headline growth of +77% and +143% overstates the business's health, because it mostly reflects price inflation on roughly flat volumes. Recent profit has also been flattered by one-offs and inventory gains. At about 31x trailing earnings and 6.5x book, the market is pricing a recovery in spreads, not the current run-rate.

On balance, Amal is a sound credit and a strategically secure business but a speculative equity. The decisive things to watch are the direction of sulphur prices and evidence, in the second half of FY2027, that contract pass-through with Atul and merchant customers is resetting. Without both, valuation risk outweighs operating quality.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure on Amal boardBackground and other rolesClassification

Sunil Siddharth Lalbhai

Chairman

Since 2010 (MCA: 24 Sep 2010)

Chairman (since 2007) and Managing Director (since 1984) of Atul Ltd; Chairman of Atul Bioscience; Vice Chairman of Atul Rajasthan Date Palms (Atul website). AR FY2023-24 refers to a postgraduate degree in Chemistry. Holds about 0.41% of Amal (Simply Wall St).

Non-executive, promoter

Rajeev Kumar

Managing Director

Since 24 Mar 2017; reappointed at the 52nd AGM, 14 Aug 2026

President of Atul Ltd. Age about 53 (Simply Wall St). Holds about 0.07%.

Executive

T R Gopi Kannan (Gopi Kannan Rengachari Thirukonda)

Director

—

Whole-time Director and CFO of Atul Ltd (Atul board archive)

Non-executive (Atul nominee)

Jyotin Kantilal Mehta

Director

Since 2022; reappointed 14 Aug 2026

—

Independent, non-executive

Dipali Chirag Sheth

Director

———

Mahalakshmi Subramanian

Director

———

Venkatraman Srinivasan

Director

———

Drushti Rahul Desai

Director

———

Executive Leadership Team

NameTitleNotes

Rajeev Kumar

Managing Director

See above

Yogesh Vyas

Chief Financial Officer

—

Ankit Mankodi

Company Secretary & Compliance Officer

Per BFSL/Nirmal Bang data. Simply Wall St shows the CS role held for about 10.6 years, which may refer to a predecessor.

M G Palekar

Listed among management

—

Directors' Remuneration

PersonSalary (INR Mn)Bonus (INR Mn)Stock (INR Mn)Total (INR Mn)Year

Rajeev Kumar, MD

1.9001.9

FY2025

Shareholding Trend

Holder categoryMar 2017Mar 2018Mar 2023Mar 2025Sep 2026

Promoters & promoter group (%)

53.7365.5171.3371.3471.35

Domestic institutions (%)

0.030.020.020.020.03

Public (%)

46.2434.4728.6628.6428.61

Major Shareholders

HolderStakeNotes

Atul Ltd, mainly through Atul Finserv Ltd

49.86%

CARE (2023–2026)

Other promoter group entities (Lalbhai group investment companies, e.g. Aayojan Resources, Adhinami Investments, Aagam Agencies, Akshita Holdings, Anusandhan Investments)

About 21.5% in aggregate (71.35% minus 49.86%)

—

Sunil Lalbhai

About 0.41%

Simply Wall St

Rajeev Kumar

About 0.07%

Simply Wall St

Mutual funds (3 schemes)

0.01%

Trendlyne

Competitive Landscape

Key Competitors

#CompanyRoute / relevance to AmalNotes
1

Kutch Copper (Adani group), Mundra, Gujarat

Smelter acid; new copper smelter in Gujarat expected to add about 1.5 million t/a of acid (CRU)

Largest new regional supply source; can pressure Gujarat merchant acid prices

2

Hindalco Industries (Birla Copper, Dahej, Gujarat)

Smelter acid

Large merchant seller in Gujarat

3

Hindustan Zinc (Vedanta group)

Smelter acid (zinc/lead)

Mainly Rajasthan; national supply

4

Vedanta / Sterlite Copper (Thoothukudi)

Smelter acid; plant has over 1.2 million t/a acid capacity (Bonafide) but has been shut since 2018

Possible restart is a supply risk

5

IFFCO (Paradeep)

Sulphur-burning, captive for phosphates; about 2.31 million t/a acid capacity (Bonafide)

Mostly captive

6

Gujarat State Fertilizers & Chemicals (GSFC), Sikka unit

New sulphur-burning acid plant of about 600,000 t/a commissioning 2025–26 (CRU)

Gujarat capacity addition

7

Coromandel International

Sulphur-burning, captive for fertilisers

Expanding sulphur-based capacity

8

Paradeep Phosphates

Sulphur-burning, captive

Fertiliser-integrated

9

Small Ankleshwar/Vapi/Dahej merchant sulphur burners (unlisted)

Direct merchant competitors in the South Gujarat chemical belt

Names and sizes not publicly disclosed

10

Imported smelter acid (Japan, Korea and others)

Imports into Indian ports; India imported about 1.8–1.9 million tonnes in 2020 (Research & Markets)

Sets coastal price ceilings

Peer Comparison FY2026

MetricAmal Ltd (FY2026)Atul Ltd (FY2026, parent/customer)

Revenue

₹239.6 cr

₹6,317 cr consolidated (CARE)

Revenue growth

77%

13% (₹5,584 cr to ₹6,317 cr, CARE)

EBITDA margin

14.9%

17.06% (CARE)

Net debt

Net cash

Group largely debt-free (Atul AGM 2026)

Recent Developments

Routine compliance filings are included where they add timeline context.

Company Snapshot

$27.7M

Revenue

81

Employees

1974

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Strong parentage. Atul (rated CARE AA+/A1+) controls 49.86%, with common management. CARE applies a parent notch-up, leading to Amal's CARE A+ (Oct 2026).
  • Captive anchor demand. About 38% of FY2026 revenue came from Atul (CARE), with committed offtake noted in CARE Oct 2024.
  • Debt-free balance sheet. Fund-based borrowings were nil at 31 Mar 2026. Interest coverage was 54.57x in FY2026 and the current ratio 2.48x (CARE).
  • Full utilisation. The plants operated at full capacity in FY2025–FY2026 (CARE).
  • Steam monetisation. About 16% of FY2026 revenue comes from by-product steam, a stream that exists only because of integration with Atul.
  • Cash generation through the cycle. CFO was ₹50 cr in FY2025 and ₹22 cr in FY2026 despite margin compression. Gross cash accruals were ₹35.0 cr in FY2026 (CARE).

Weaknesses

  • Single product group. CARE names this as a key rating weakness; sulphur-based products are 84% of revenue.
  • Raw-material concentration. Sulphur is about 85% of costs (CARE Oct 2026). EBITDA margin halved from 32.3% to 14.9% in FY2026.
  • Limited pass-through. In FY2026, realisation rose 93% while EBITDA fell 18% (CARE).
  • Small scale. Revenue is ₹240 cr, about 3.8% of Atul's revenue, and the workforce numbers only dozens (32–81 employees per sources).
  • Earnings quality noise. Q1 FY2027 included ₹5.61 cr of one-off incentive income. Q4 FY2026 had a 66% tax rate. Quarterly OPM ranged from 6.5% to 44.6% across FY2025–FY2027.
  • Thin public float and liquidity. The public holds 28.61% and institutions only 0.03%. Daily volumes are small (for example, 2,769 shares on one Nirmal Bang snapshot). The stock moved ±20% on results days in Jul and Oct 2026.

Opportunities

  • SO2 expansion from 45 to 105 TPD. Capex is about ₹12 cr; current capacity is almost fully used.
  • Steam pipeline. Part of the ~₹25 cr programme; could raise steam volumes and revenue.
  • Sulphur storage. Allows procurement timing gains and buffering against supply shocks (CARE). Inventory-led gains already helped Q1 FY2027.
  • Atul's growth. Atul's FY2026 revenue rose 13% to ₹6,317 cr. More aromatics and intermediates output increases acid and steam demand next door.
  • Further capacity tied to Atul. CARE lists a significant increase in Atul offtake as a positive rating sensitivity, which implies room for further captive expansion.
  • Normalisation of sulphur prices. A reversal from about US$1,050/MT would restore spreads. FY2025 margins of 32% were achieved at about US$157/MT.

Threats

  • Sulphur shock persistence. Prices rose about 2.5x from the FY2026 average to about US$1,050/MT, driven by West Asia conflict (CARE). Q2 FY2027 OPM was 6.45%.
  • Regional oversupply. The Adani copper smelter is set to add about 1.5 million t/a of acid (CRU), and GSFC Sikka about 0.6 million t/a.
  • Environmental regulation. Evolving pollution-control norms could raise costs or disrupt operations (CARE). Ankleshwar is a closely monitored industrial cluster.
  • Dependence on Atul's credit and strategy. CARE names deterioration of Atul or weaker linkages as a downgrade trigger.
  • Related-party pricing risk for minorities. With a 38% revenue share from the controlling shareholder, transfer-pricing terms affect minority returns. Terms are not publicly disclosed in detail.
  • Plant concentration. All capacity is at a single location, Ankleshwar. Planned shutdowns already cut Q1 volumes by about 15%; an unplanned outage would hit the whole company.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
–FY2025 results: record revenue of ₹135 cr and PAT of ₹29.3 cr; first dividend of 10% (₹1 per share)Validated the reinvented model; start of shareholder payouts
Jul 2025Q1 FY2026: revenue ₹47.3 cr, PAT ₹9.4 cr, OPM 24.6%Strong start despite annual planned shutdown
6 Aug 2025Record/book-closure date for the 51st AGM and dividend (Emkay)Corporate action
29 Aug 202551st AGM; SPANJ & Associates appointed secretarial auditor until the 56th AGMGovernance compliance with Regulation 24A
12 Sep 2025CARE reaffirms A+; Stable. Notes debt-free status and about 35% revenue from Atul.Credit stability
11 Oct 2025Shareholding pattern for Sep 2025: promoters 71.34%, public 28.65%Stable control
15 Oct 2025Q2 FY2026: standalone PAT down 38% to ₹1.09 cr; consolidated PAT ₹6.06 cr; OPM falls to 15.9%First visible sulphur-cost squeeze
19 Dec 2025Stock closes at ₹686.90; P/E about 21.9x; 1-year return about +42% (ICICIdirect)Valuation context
24 Dec 2025Board meeting intimation for Q3 resultsRoutine
–Q3 FY2026: revenue ₹62.6 cr, PAT ₹5.0 cr, OPM 12.9%Margin erosion continues
17 Jan 2026Regulation 74(5) compliance certificate filedRoutine
2 Feb 2026Stock trades near ₹462 against a 52-week high of ₹1,148 (Emkay)De-rating amid margin compression
9–11 Apr 2026BSE seeks clarification on price movement; company replies that the trading window is closed 1–24 Apr ahead of resultsUnusual price/volume activity
15 Apr 2026Board meeting intimation for FY2026 resultsRoutine
22 Apr 2026FY2026 audited results: revenue ₹240 cr (+77%), PAT ₹22.4 cr (−24%); 15% dividend; reappointment of Rajeev Kumar (MD) and Jyotin MehtaRevenue/margin divergence confirmed
30 Apr 2026Record date of 31 Jul 2026 set for dividendCorporate action
19 May 2026Annual secretarial compliance report for FY2026 filed, reporting full complianceGovernance
Apr–Jun 2026Annual planned shutdown for maintenance during Q1 FY2027Volume impact (about −15% year on year per CARE)
17 Jul 2026Q1 FY2027: revenue ₹96.5 cr (+104%), PAT ₹16.7 cr (+78%), helped by ₹5.61 cr incentive and inventory gains. ₹12 cr SO2 expansion approved. Stock hits 20% upper circuit at ₹752.15.Major positive catalyst; first growth capex since ASCL
31 Jul 2026Dividend record date (₹1.5 per share)Payout
14 Aug 202652nd AGM held; dividend and reappointments approved. Stock about ₹750, P/E 31.5x, P/B 7.7x (ICICIdirect).Governance
FY2027 to dateSulphur prices climb to about US$1,050/MT on West Asia conflicts and supply-chain disruption (CARE)Main input-cost shock
25 Sep 2026Board meeting intimation for 16 Oct; trading window closed 1–18 OctRoutine
8 Oct 2026Regulation 74(5) certificate for Sep 2026 quarterRoutine
9 Oct 2026CARE reaffirms A+; Stable. Limits raised to ₹20 cr. ~₹25 cr capex plan disclosed (SO2, steam pipeline, sulphur storage).Confirms credit strength and capex plan
16 Oct 2026Q2 FY2027: revenue ₹131.2 cr (+143%), OPM 6.45% (vs 15.93%), PAT ₹6.16 cr (+1.7%). Standalone PAT ₹4.01 cr. Stock falls 20% to ₹746.Severe margin compression; sharp de-rating

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 430 Mn in FY2022 to INR 2,396 Mn in FY2026.
Amal Ltd — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations4306108601,3532,396

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. CARE Ratings, Amal Limited press releases: 9 Oct 2026 ( 12 Sep 2025; 10 Oct 2024; 27 Sep 2023. (careratings.com)
  2. Screener.in, Amal Ltd consolidated financials, shareholding and announcements ( accessed Oct 2026. (screener.in)
  3. Amal Ltd Directors' Report FY2025-26 (via Goodreturns, IIFL) and FY2024-25 (via IIFL); Annual Reports FY2023-24, FY2022-23, FY2020-21, FY2018-19, FY2015-16, FY2008-09 (BSE / Atul website).
  4. BSE filing, Rights Issue allotment, 21 Mar 2023; BSE board outcomes, 16 Oct 2026.
  5. Atul Ltd Integrated Annual Report FY2024-25; Atul AGM Presentation 2026; Atul Annual Report FY2016-17 (BIFR note).
  6. Capital Market news via JM Financial Services: Q1 FY2027 (17 Jul 2026) and Q2 FY2027 (16 Oct 2026).
  7. FilingReader: Q1 FY2027 filing summary (17 Jul 2026).
  8. Trendlyne: Q1 FY2027 results notes; shareholding.
  9. Simply Wall St: company information and management data.
  10. Value Research, ICICIdirect, Kotak Neo, Upstox, INDmoney, Emkay, Nirmal Bang, BFSL/Vogue: price, valuation and management data.
  11. IIFL / Kotak Securities company histories; Zauba Corp and TheCompanyCheck (MCA data).
  12. IMARC Group; Research & Markets; Bonafide Research; CRU/BCInsight (Nov 2024, Nov 2025); Chemical Weekly (Oct 2023): industry context.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.